ITLN1 and inflammatory bowel disease: Our findings suggest novel mechanisms by which UPR-regulated ITLN1 may affect the host’s susceptibility to intestinal inflammation in the colon that could act in addition to other mechanisms known to mediate abnormal inflammatory responses in IBD with colonic involvement (Caruso et al., 2020).